You are currently viewing the abstract.
View Full TextLog in to view the full text
AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.
More options
Download and print this article for your personal scholarly, research, and educational use.
Buy a single issue of Science for just $15 USD.
Abstract
Leukotrienes are arachidonic acid–derived lipid mediators of inflammation. The initial catalytic step in the formation of leukotrienes is catalyzed by 5-lipoxygenase (5-LOX) in conjunction with its activating partner protein FLAP. The long-awaited crystal structure of 5-LOX—reported in a recent issue of Science—should lead to novel, purpose-designed inhibitors for the treatment of asthma and for probing leukotriene involvement in cardiovascular disease and cancer.
Footnotes
-
Citation: C. D. Funk, Leukotriene Inflammatory Mediators Meet Their Match. Sci. Transl. Med. 3, 66ps3 (2011).
- Copyright © 2011, American Association for the Advancement of Science
